Early anticoagulation after bioprosthetic aortic valve replacement didn’t result in adverse clinical events or significantly affect aortic valve hemodynamics in a recent analysis of 4,832 heart patients, but it was linked to lower stroke rates in cases of SAVR.

Belgium-based Miracor Medical has secured FDA breakthrough device designation for its PiCSO Impulse System, an innovation designed to treat STEMI patients.

KentuckyOne Health is nixing its month-old plan to inactivate its heart transplant program at Jewish Hospital in Louisville, instead opting to work with the University of Louisville to keep the program alive.

Childhood cancer survivors are up to three times more likely than their cancer-free peers to develop various types of heart disease, according to an Aug. 26 study published in Circulation.

A multi-country study in Asia has revealed patients with both type 2 diabetes and heart failure face higher odds of structural CV abnormalities, a poorer quality of life and an increased risk of death.

Research published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes this month suggests owning a pet—in particular a dog—can be beneficial for cardiovascular health.

A study of more than 181,000 patients at the Mayo Clinic has proven the efficacy of an AI algorithm in spotting AFib on seemingly normal EKGs, the Daily Mail reports.

Managing new-onset HF is a delicate task for cardiologists, and one that demands an appropriate balance between aggressive treatment and optimal quality of life for the patient. But that balance may be harder to strike than previously thought, researchers reported in Circulation this month.